The 10 Biggest Clinical Success Stories of 2016 in European Biotech
What are the most impressive advances in medical biotechnology this year? From cancer to peanut…
22/12/2016 - 5 minutes
DBV Technologies
The First Peanut Allergy Therapy might soon hit the Shelves
DBV Technologies announced outstanding Phase IIb results for Viaskin Peanut, which could be the first-ever…
25/10/2016 - 3 minutes
“This Phase I could Pioneer Needle-free Vaccines”, DBV’s CEO
How annoying are needle vaccinations? Very ... But the French billion-euro Biotech DBV Technologies wants…
06/09/2016 - 3 minutes
Which European Biotechs made it to the Billion-Euro Club in 2016?
Europe has a lot of successful Biotech companies, but which of those are worth a billion euros or more?…
12/07/2016 - 6 minutes
DBV Technologies: “This is our First and most Significant Partnership signed”
The billion-euro Biotech from Paris DBV Technologies just signed a €100M deal with Nestlé Health…
31/05/2016 - 4 minutes
DBV: “These Additional Results Confirm our Potential of solving the Peanut Allergy problem Worldwide”
DBV Technologies (Paris) was just under the spotlight in Los Angeles at the biggest allergy convention worldwide (2016…
14/03/2016 - 6 minutes
7 Trendy European Biotechs Listed on the NASDAQ in 2016
Here are 7 European Biotechs listed on the NASDAQ we thought were worth mentioning in more…
23/02/2016 - 6 minutes
Peanut Allergies? This Phase III Trial Could Mean an End to Nut-Related Anaphylaxis
Peanut allergy in children can be life-threatening, with safe treatment options available. Now DBV Technologies…
10/12/2015 - 2 minutes
The 9 EU-based Billion-Euro Biotechs you Should (really) Know
Update 22/10/2015: I added Galapagos from Belgium and Basilea from Switzerland, they deserved it ...…
15/09/2015 - 6 minutes
Paris is Europe’s biggest Biocluster, but nobody knows it …
Paris is well-known for being the most beautiful city in the world. But did you…
19/08/2015 - 5 minutes
The Metamorphosis of Biopharmaceutical Innovation #BIO-Europe2015
Innovation can occur in many different ways, and biopharmaceutical innovation is no exception. The pipelines of…
26/03/2015 - 6 minutes
New Technologies Against Allergies are on the Wave
Anergis, a company developing proprietary ultra-fast allergy vaccines, closed a Series B financing round totaling 12,1…
03/12/2014 - 2 minutes
